Physician profile
Dustin Van Orman
NPI 1013292481
$8,253.95
in general payments reported to CMS, 2019-2025
23 companies · $1,123 in 2025
The $1,123 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,983 · 2022: $2,029 · 2023: $1,804 · 2024: $1,315 · 2025: $1,123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,241.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,147.87 | 2021-2025 | Penta, Proclaim, Eterna |
| Medtronic, INC. | $914.77 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Boston Scientific Corporation | $447.73 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Coveredge 32 |
| Biotronik Nro, INC. | $367.98 | 2023-2025 | Prospera, Biotronik |
| Stryker Corporation | $260.96 | 2021-2023 | Monterey Al |
| Astrazeneca Pharmaceuticals LP | $216.21 | 2022-2024 | Andexxa, Brilinta |
| Pacira Pharmaceuticals Incorporated | $147.34 | 2021-2025 | Exparel |
| Si-Bone, INC. | $131.27 | 2022 | |
| Nevro Corp. | $107.61 | 2021-2024 | Senza |
| Nexxt Spine LLC | $60.12 | 2023 | Nexxt Matrixx Sa Alif |
| Sanara Medtech INC. | $56.45 | 2025 | Biasurge, Celleraterx |
| Augmedics INC. | $56.35 | 2024 | Xvision |
| Nalu Medical, INC. | $52.52 | 2021 | |
| Livanova USA, INC. | $43.55 | 2021-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Melinta Therapeutics, LLC | $42.16 | 2023-2024 | Kimyrsa, Rezzayo |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argenx US, INC. | $36.26 | 2023 | Vyvgart |
| Biocomposites INC | $33.40 | 2025 | Stimulan |
| Spineart USA INC | $32.32 | 2022 | |
| Forte Bio-Pharma LLC | $31.54 | 2021 | |
| Curonix LLC | $22.09 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Protega Pharmaceutials INC | $15.55 | 2025 | Roxybond |
| Kls-Martin L.P. | $15.53 | 2025 | |
| Painteq LLC | $14.37 | 2024 | Painteq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dustin Van Orman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.